ReviewOpen forum infectious diseases2018
Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value.
Natalia Olchanski et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
44 papers cite it
this paperpooled itcites it